The October Pistoia Alliance / QED-C / QuPharm / QPARC – Quantum Computing Community of Interest will feature a presentation by Robert Marino, CEO of Qubit Pharmaceuticals.
Qubit Pharmaceuticals has just finished an impressive seed funding round raising an impressive 23M EUR, and is investing heavily in their Atlas software platform, leveraging supercomputers and quantum computers with a goal of accelerating drug development. As a Pistoia Alliance member company, Qubit pharmaceuticals is eager to discuss opportunities for standardization by initiating a Pistoia Alliance cross-company collaborative project.
The preliminary October meeting agenda is as follows:
16:00 – 16:30 (GMT) a presentation by Robert Marino, CEO, Qubit Pharmaceuticals on Qubit pharmaceuticals’ experience and opportunities for standardization within a Pistoia Alliance cross-company collaborative project.
16:30 – 16:55 (GMT) Open discussion to address how a Pistoia Alliance collaborative project can address the need for standardization as the biopharma industry adopts quantum computing
16: 55 – 17:00 (GMT) Community of Interest Next Steps: (Technology Observatory, Education, Standardisation, Call for Sponsors)
To attend, please contact email@example.com
For details on your company becoming a member company of the Pistoia Alliance: https://www.pistoiaalliance.org/membership/